Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Irritable Bowel Syndrome, November 2025 Free Subscription Abstracts Retrieve all available abstracts of the following 87 articles: HTML format

Single Articles

1. LEE G, Lee MH, Park SE, Pak J, et al
   Prediction of irritable bowel syndrome by integrating urine metabolites and gut microbiota.
   Sci Rep. 2025;15:38246.
   PubMed    
   Abstract available
   
   

2. FONTE AACFRD, Cunha-Silva M, Rondon MVSDS, Santos CRD, et al
   SMOKING IMPACTS HELICOBACTER PYLORI ERADICATION: RESULTS FROM A BRAZILIAN UNIVERSITY HOSPITAL.
   Arq Gastroenterol. 2025;62:e25059.
   PubMed    
   Abstract available
   
   

3. CHOI NR, Ko SJ, Choi WG, Jung D, et al
   Therapeutic effects of Poncirus fructus on colonic dysfunction and visceral pain in a zymosan-induced irritable bowel syndrome mouse model through interstitial cells of Cajal and ion channel modulation.
   Front Pharmacol. 2025;16:1639592.
   PubMed    
   Abstract available
   
   

4. GARAGA GSS, Maninithya K, Deepica Rani N, Dayan A, et al
   Comparative study of fecal calprotectin levels in ulcerative colitis versus irritable bowel syndrome.
   Bioinformation. 2025;21:1850-1853.
   PubMed    
   Abstract available
   
   

5. SONG L, Lee H, Choi JS, Park S, et al
   Synergistic Modulation of the Gut-Brain-Immune Axis by a Dual Lactobacillus Combination in a Murine IBS Model.
   J Microbiol Biotechnol. 2025;35:e2507018.
   PubMed    
   Abstract available
   
   

6. BROWNLOW G, Flack R, Burton-Murray H, Palsson O, et al
   The Prevalence and Burden of Avoidant/Restrictive Food Intake Disorder (ARFID) Symptoms in the Adult General Population of the UK and USA.
   Int J Eat Disord. 2025 Oct 29. doi: 10.1002/eat.24588.
   PubMed    
   Abstract available
   
   

7. AL-JUHANI A, Desoky MS, Nasir Ahmad M, Alharthi A, et al
   Tenapanor for Irritable Bowel Syndrome With Constipation (IBS-C): A Systematic Review of Randomized Trials Assessing Food and Drug Administration (FDA) Composite Response, Durability, and Risk-of-Bias (RoB-2).
   Cureus. 2025;17:e93337.
   PubMed    
   Abstract available
   
   

8. AJABNOOR SM
   Effects of meal regularity and snacking frequency on irritable bowel syndrome.
   Front Public Health. 2025;13:1675975.
   PubMed    
   Abstract available
   
   

9. BANG WY, Moon JS, Kim H, Lee HB, et al
   Therapeutic Modulation of the Gut Microbiome by Supplementation with Probiotics (SCI Microbiome Mix) in Adults with Functional Bowel Disorders: A Randomized, Double-Blind, Placebo-Controlled Trial.
   Microorganisms. 2025;13:2283.
   PubMed    
   Abstract available
   
   

10. CHOMENTOWSKI A, Drygalski K, Kleszczewski T, Berczynska M, et al
    Polyphenols as Modulators of Gastrointestinal Motility: Mechanistic Insights from Multi-Model Studies.
    Pharmaceuticals (Basel). 2025;18:1564.
    PubMed    
    Abstract available
    
    

11. NEUFELD A, Bradshaw EL
    Linking Life Aspirations to Functional Medical Conditions: A Goal Contents Theory Perspective.
    Int J Environ Res Public Health. 2025;22:1582.
    PubMed    
    Abstract available
    
    

12. SAAVEDRA-BRAVO R, Mendez-Tenorio A, Lopez-Luis MA, Davila-Martinez EA, et al
    Description of the Distinctive Changes in the Colonic Microbiome Associated with Irritable Bowel Syndrome, Uncomplicated Diverticulitis, and Tubular Adenoma.
    Biomedicines. 2025;13:2424.
    PubMed    
    Abstract available
    
    

13. JOHNSSON A, Ljotsson B, Braunschweig F, Mellbin LG, et al
    Digital cognitive behavioural therapy for cardiac anxiety following acute coronary syndrome: protocol for a randomised controlled trial comparing CBT to a digital lifestyle intervention.
    BMJ Open. 2025;15:e106473.
    PubMed    
    Abstract available
    
    

14. LEE YS, Lee S, Kim S
    Differential Effects of Probiotic Strains on Chronic Stress-Exacerbated Colonic Motility in Rats: A Comparative Evaluation.
    Metabolites. 2025;15:677.
    PubMed    
    Abstract available
    
    

15. VARMA S, Dicken Q, Silvernale C, Kochar B, et al
    Low Rates of Physiologic Testing and Prescription Drug Use for FC and IBS-C in Patients With Inflammatory Bowel Disease.
    Neurogastroenterol Motil. 2025 Oct 27:e70161. doi: 10.1111/nmo.70161.
    PubMed    
    Abstract available
    
    

16. VERMEIJDEN NK, Oorthuys A, Groen J, Thapar N, et al
    Current and novel therapeutic strategies in pediatric irritable bowel syndrome and functional abdominal pain-not otherwise specified.
    Expert Opin Pharmacother. 2025 Oct 29:1-15. doi: 10.1080/14656566.2025.2582017.
    PubMed    
    Abstract available
    
    

17. JIMENEZ-VARGAS NN, Parkar N, Takami K, Wood HM, et al
    Emerging therapeutic approaches for treating abdominal pain.
    J Can Assoc Gastroenterol. 2025;8:152-162.
    PubMed    
    Abstract available
    
    

18. NAJEEB R, Kanuri SH, Patel VJ, Ansari AZ, et al
    Lymphocytic Colitis With Ileal Extension Following Oyster Consumption: A Case Report.
    Cureus. 2025;17:e93190.
    PubMed    
    Abstract available
    
    

19. PFANZAGL B, Jensen-Jarolim E
    Protease-Activated Receptor 2 Activation Provokes an Increase in Intracellular Calcium and Serotonin Secretion in a Human Enteroendocrine Cell Line.
    Cell Biochem Funct. 2025;43:e70132.
    PubMed    
    Abstract available
    
    

20. ROTH B, D'Amato M, Ohlsson B
    Improved lipid and glycemic profile and vitamin D levels after a dietary intervention with SSRD and low FODMAP in IBS patients: A randomized controlled trial.
    Nutrition. 2025;142:112964.
    PubMed    
    Abstract available
    
    

21. RANA A, Smriti
    Probiotics: mechanism of action and gastrointestinal health: gut guardians: unlocking the power of probiotics.
    J Sci Food Agric. 2025 Oct 25. doi: 10.1002/jsfa.70275.
    PubMed    
    Abstract available
    
    

22. MA Q, Jiang Z, Zhang Z, Sun L, et al
    Qizhiweitong granule alleviates diarrhea-predominant irritable bowel syndrome via inhibition of the IL-6/Src/STAT3 feedback loop.
    J Ethnopharmacol. 2025 Oct 22:120772. doi: 10.1016/j.jep.2025.120772.
    PubMed    
    Abstract available
    
    

23. PAINE P
    Chronic Abdominal Pain: Practical Approaches.
    Br J Hosp Med (Lond). 2025;86:1-15.
    PubMed    
    Abstract available
    
    

24. ROY YJ, Mirani Y, Raju J, Ali AHM, et al
    The Role of Colonic Microbiota in Constipation Predominant Irritable Bowel Syndrome: A Literature Review.
    Br J Hosp Med (Lond). 2025;86:1-11.
    PubMed    
    Abstract available
    
    

25. BAUMGARTNER M, Gasche C
    Ileal Biofilms Confirm SIBO-IBS Hypothesis: Comment on PMID 38798120.
    Neurogastroenterol Motil. 2025 Oct 24:e70183. doi: 10.1111/nmo.70183.
    PubMed    
    
    
    

26. JIN Z, Chen M, Ao L, Wang J, et al
    GABA-producing Lactococcus lactis alleviates gut dysfunction and neurobehavioral abnormalities associated with irritable bowel syndrome.
    Microbiome Res Rep. 2025;4:34.
    PubMed    
    Abstract available
    
    

27. CHA B, Shin JE, Na W, Kim SE, et al
    [Irritable Bowel Syndrome].
    Korean J Gastroenterol. 2025;85:459-466.
    PubMed    
    Abstract available
    
    

28. PATHIPATI MP, Shortt A, Shortt C, McBride B, et al
    Impact of Short Duration FODMAP Restriction on Breath Gases and Gastrointestinal Symptoms.
    Clin Transl Gastroenterol. 2025;16:e00886.
    PubMed    
    Abstract available
    
    

29. DILMAGHANI S, Lupianez-Merly C, BouSaba J, Vijayvargiya P, et al
    Simplifying Diagnosis of Bile Acid Diarrhea With Clinical and Biochemical Measurements on Blood and Single Stool Sample.
    Clin Gastroenterol Hepatol. 2025;23:2318-2327.
    PubMed    
    Abstract available
    
    

30. LUO Q, Wang J, An M, Zhang L, et al
    Bidirectional genetic overlap between mood swings and irritable bowel syndrome.
    Psychiatr Genet. 2025;35:154-165.
    PubMed    
    Abstract available
    
    

31. SOMMERMEYER H, Ciesla M, Szczerbiec D, Olszewski P, et al
    Coping with the burden of irritable bowel syndrome by emotional suppression-A cross sectional observational pilot study.
    J Gen Fam Med. 2025;26:555-562.
    PubMed    
    Abstract available
    
    

32. AMIEVA-BALMORI M, Martinez-Perez GP, Remes-Troche JM
    Response to the letter to the editor regarding our article: "Dietary characteristics of Mexican patients with irritable bowel syndrome: Is there a distinction from the general population?".
    Rev Gastroenterol Mex (Engl Ed). 2025 Nov 4:S2255-534X(25)00150.
    PubMed    
    
    
    

33. MENG S, Berna R, Hoffstad O, Takeshita J, et al
    Epithelial Barrier Diseases Among Adult Patients With Seborrheic Dermatitis.
    JAMA Dermatol. 2025 Nov 5:e254313. doi: 10.1001/jamadermatol.2025.4313.
    PubMed    
    Abstract available
    
    

34. HONG D, Xiao Y
    Shaoyao Gancao Decoction: a comprehensive review of modern clinical applications and underlying pharmacological mechanisms.
    Front Pharmacol. 2025;16:1656217.
    PubMed    
    Abstract available
    
    

35. XIAO YL, Jia YQ, Gu LQ, Chen MH, et al
    Prevalence of Celiac Disease in China Among High-Risk Populations: A Systematic Review and Meta-Analysis.
    J Dig Dis. 2025 Nov 3. doi: 10.1111/1751-2980.70013.
    PubMed    
    Abstract available
    
    

36. JOSHI DC, Raina N, Joshi N, Gurow K, et al
    Current Landscape of Novel Therapeutic Agents and Drug Targets in Irritable Bowel Syndrome.
    Arch Pharm (Weinheim). 2025;358:e70133.
    PubMed    
    Abstract available
    
    

37. SHRESTHA UK
    Emerging role of artificial intelligence in gastroenterology and hepatology.
    World J Gastroenterol. 2025;31:111495.
    PubMed    
    Abstract available
    
    

38. HASHEMPOUR B, Ansari FK, Asadiof F, Naeim M, et al
    Psychological self-efficacy and coping styles as mediators between perceived stress and IBS symptom severity: a cross-sectional study.
    Ann Med Surg (Lond). 2025;87:7030-7035.
    PubMed    
    Abstract available
    
    

39. LU S, Li L, Zhuang Y, Ye F, et al
    Night shift work increases the risk of developing irritable bowel syndrome: a prospective cohort study in the UK Biobank.
    Front Public Health. 2025;13:1651752.
    PubMed    
    Abstract available
    
    

40. KEZER G, Paramithiotis S, Khwaldia K, Harahap IA, et al
    A comprehensive overview of the effects of probiotics, prebiotics and synbiotics on the gut-brain axis.
    Front Microbiol. 2025;16:1651965.
    PubMed    
    Abstract available
    
    

41. YUAN PQ, Nash M, Li T, Mahurkar-Joshi S, et al
    Altered Sigmoid Mucosal Innervation and Mast Cell Proximity to Sensory Nerve Fibers Are Associated With Symptom Severity in Patients With Irritable Bowel Syndrome.
    Neurogastroenterol Motil. 2025 Nov 2:e70199. doi: 10.1111/nmo.70199.
    PubMed    
    Abstract available
    
    

42. SBARIGIA C, Lambiase C, Butt MF, Aliyu AI, et al
    Clinical Characteristics and Outcomes of Rome IV Diarrhea-Predominant Irritable Bowel Syndrome and Functional Diarrhea Prescribed With Ondansetron: A Real-World Study.
    Neurogastroenterol Motil. 2025 Nov 2:e70193. doi: 10.1111/nmo.70193.
    PubMed    
    Abstract available
    
    

43. XU B, Zhang J, Huang Y, Wang X, et al
    Multi-Omics and Mendelian-Randomization Investigation of Mitochondrial Genes in Irritable Bowel Syndrome.
    Curr Med Chem. 2025 Oct 29. doi: 10.2174/0109298673409785250925143312.
    PubMed    
    Abstract available
    
    

44. YANG J, Wang Y, Wang S, Liu Z, et al
    Unraveling the active ingredients and molecular mechanisms of Qinghua Changyan granule against irritable bowel syndrome with diarrhea: Effects on gut microbiota and glutamine transport via an integrative approach combining UHPLC-MS/MS and experimental
    Fitoterapia. 2025 Oct 30:106960. doi: 10.1016/j.fitote.2025.106960.
    PubMed    
    Abstract available
    
    

45. LI X, Ouyang G, Li Y, Qu L, et al
    Insular cortex mediates chronic restraint stress-induced irritable bowel syndrome-like behaviors via glucocorticoid signaling.
    Neurobiol Dis. 2025 Nov 11:107180. doi: 10.1016/j.nbd.2025.107180.
    PubMed    
    Abstract available
    
    

46. KHANNA S, Yoho D, Van Handel D, Clark BJ, et al
    Prevention of recurrent Clostridioides difficile infection by fecal microbiota, live-jslm (REBYOTA((R))) administered via colonoscopy: 6-month data from the single-arm phase IIIb CDI-SCOPE trial.
    Therap Adv Gastroenterol. 2025;18:17562848251396744.
    PubMed    
    Abstract available
    
    

47. ALHASYANI T, Ebeid T, Ghonimy M, Alharbi S, et al
    Harnessing Edible Insect Bioactives for Gut Health: A Comprehensive Review on Chitin-Derived Prebiotics and Peptidomic Insights from the Black Soldier Fly.
    Foods. 2025;14:3654.
    PubMed    
    Abstract available
    
    

48. KARAKULAH YS, Yalcintas YM, Bechelany M, Karav S, et al
    Clinical Applications of Bovine Colostrum in GastrointestinaI Disorders: Mechanisms, Evidence, and Therapeutic Potential.
    Int J Mol Sci. 2025;26:10673.
    PubMed    
    Abstract available
    
    

49. AGGELETOPOULOU I, Papantoniou K, Pastras P, Triantos C, et al
    Unraveling the Pathophysiology of Irritable Bowel Syndrome: Mechanisms and Insights.
    Int J Mol Sci. 2025;26:10598.
    PubMed    
    Abstract available
    
    

50. JACOBSEN SA, Petersen MW, Wellnitz KB, Ornbol E, et al
    Functional Somatic Disorders in Individuals With a History of Sexual Assault.
    JAMA Psychiatry. 2025 Nov 12. doi: 10.1001/jamapsychiatry.2025.3251.
    PubMed    
    Abstract available
    
    

51. MOU J, Xu L, Luo Y, Tao Q, et al
    Assessing the Efficacy of Functional Food as Treatment for Irritable Bowel Syndrome with Constipation: A Systematic Review and Network Meta-Analysis.
    Nutr Rev. 2025 Nov 10:nuaf204. doi: 10.1093.
    PubMed    
    Abstract available
    
    

52. JIN X, Guo P, Jin X, Xia W, et al
    Saccharomyces boulardii's impact on pediatric diarrhea-predominant irritable bowel syndrome: animal model findings.
    Pediatr Res. 2025 Nov 10. doi: 10.1038/s41390-025-04482.
    PubMed    
    Abstract available
    
    

53. BRIONI F, Sabbadini O, Torkelson B
    Gut Instincts: Why Dietary Fiber Matters in Growing Kids.
    Pediatr Ann. 2025;54:e382-e386.
    PubMed    
    Abstract available
    
    

54. RAYYAN R, Gainsburg V, Berkemeyer A
    Low FODMAP and Gluten-Free Diet Implementation: A Guide for the General Practitioner.
    Pediatr Ann. 2025;54:e387-e392.
    PubMed    
    Abstract available
    
    

55. LI Y, Jiao Y, Wang M, Hu J, et al
    Discovering Potential Drug Targets for Irritable Bowel Syndrome Through Genetic Insights: A Mendelian Randomization and Colocalization Study.
    Gastroenterol Res Pract. 2025;2025:7800569.
    PubMed    
    Abstract available
    
    

56. YANG Y, Spiegel BMR, Chey WD, Choi SY, et al
    Racial and Ethnic Disparities in Pandemic-Onset Disorders of Gut-Brain Interaction: Results From a Nationwide Survey.
    Neurogastroenterol Motil. 2025 Nov 7:e70200. doi: 10.1111/nmo.70200.
    PubMed    
    Abstract available
    
    

57. CHATTERJEE S, Chakraborty A, Roy S, Roychowdhury D, et al
    DEFB4A/hBD2, a non-invasive serum biomarker for detection of ulcerative colitis.
    Sci Rep. 2025;15:38949.
    PubMed    
    Abstract available
    
    

58. PATRIDGE E, Gorakshakar A, Molusky MM, Ogundijo O, et al
    Altered gut microbial functional pathways in people with irritable bowel syndrome enable precision health insights.
    BMC Gastroenterol. 2025;25:823.
    PubMed    
    Abstract available
    
    

59. REN YP, Chan WL, Chuah KH, Kim YS, et al
    Bali Chronic Constipation Roundtable Report: Chronic Constipation Management in Asia.
    J Neurogastroenterol Motil. 2025 Nov 20. doi: 10.5056/jnm25076.
    PubMed    
    Abstract available
    
    

60. MEI X, Wang W, Li XF, Pan HD, et al
    [Acupoint application therapy for diarrhea-predominant irritable bowel syndrome with spleen deficiency and dampness retention: a randomized controlled trial].
    Zhen Ci Yan Jiu. 2025;50:1317-1324.
    PubMed    
    Abstract available
    
    

61. WEEDON-FEKJAER MS, Pihlstrom HK, Weedon-Fekjaer H, Berentsen B, et al
    Gastrointestinal symptoms in adults with Fabry disease and their associations with physical and mental health.
    BMC Gastroenterol. 2025;25:819.
    PubMed    
    Abstract available
    
    

62. KIP M, Bozan GS, Sahin GA
    Large Language Models for Dietary Advice to Patients With Irritable Bowel Syndrome: ChatGPT vs. Google Gemini.
    J Hum Nutr Diet. 2025;38:e70162.
    PubMed    
    Abstract available
    
    

63. ABDELSHAFI A, Osama B, Abdelhamid ZG, Hamdallah A, et al
    Irritable bowel syndrome and associated mental health problems among Middle East and North African medical students: a multicentric cross-sectional study.
    BMC Public Health. 2025;25:3968.
    PubMed    
    Abstract available
    
    

64. ZHANG L, He J, Wang R, Yang P, et al
    Multitarget actions of TongXie-Ning granules against the gut dysfunctions of diarrhea-predominant irritable bowel syndrome.
    J Ethnopharmacol. 2025;357:120906.
    PubMed    
    Abstract available
    
    

65. MAKOWSKI AC, Barbek R, Toussaint A, Lowe B, et al
    Measuring anticipated stigma towards irritable bowel syndrome (IBS) in the German general population: testing the applicability of a modified version of the Perceived Stigma Scale of IBS in the cross-sectional SOMA.SOC study.
    BMJ Open. 2025;15:e097149.
    PubMed    
    Abstract available
    
    

66. BLOMQUIST M, Karsten J, Larsen B, Graf E, et al
    A case of delayed diagnosis of disseminated coccidioidomycosis highlights opportunities for improved awareness.
    ASM Case Rep. 2025;1:e00098-24.
    PubMed    
    Abstract available
    
    

67. ALI O, Monrroy M, Lightle A, Faddoul G, et al
    Oxalate nephropathy precipitated by linaclotide in a high-risk patient.
    Clin Nephrol Case Stud. 2025;13:66-72.
    PubMed    
    Abstract available
    
    

68. SAPS M, Arrizabalo S
    Treatment of pediatric abdominal pain: what is the evidence?
    Expert Rev Gastroenterol Hepatol. 2025.
    PubMed    
    Abstract available
    
    

69. SCHNEDL WJ, Michaelis S, Enko D, Holasek SJ, et al
    Extra increase in exhaled hydrogen during fructose malabsorption breath tests is linked to additional food intolerance/malabsorption and/or Helicobacter pylori.
    Clin Nutr ESPEN. 2025 Nov 13:S2405-4577(25)03001.
    PubMed    
    Abstract available
    
    

70. RUAN J, Yang D, Geng Q, Hao J, et al
    Bioactive flavonoids from Ohwia caudata stems influence small intestinal motility ex vivo.
    Bioorg Chem. 2025;167:109236.
    PubMed    
    Abstract available
    
    

71. CZUBER-DOCHAN W, Wileman V, Dibley L, Shankavi P, et al
    Process evaluation findings contradict RCT results of the IBD-BOOST digital self-management intervention for fatigue, pain and faecal urgency in inflammatory bowel disease: A mixed methods study of patient perspectives.
    Br J Health Psychol. 2025;30:e70035.
    PubMed    
    Abstract available
    
    

72. RUSSO F, Bianco A, Prospero L, Laselva G, et al
    Physical capacity modulates intestinal barrier dysfunction in functional disorders: phenotype-specific patterns in fibromyalgia and irritable bowel syndrome.
    Front Physiol. 2025;16:1695163.
    PubMed    
    Abstract available
    
    

73. DIMIDI E, van der Schoot A, Barrett K, Farmer AD, et al
    British Dietetic Association Guidelines for the Dietary Management of Chronic Constipation in Adults.
    Neurogastroenterol Motil. 2025;37:e70173.
    PubMed    
    Abstract available
    
    

74. SHIN A, Staller K, Levinthal DJ
    Actionable Clinical Features and Biomarkers to Facilitate the Management of Irritable Bowel Syndrome.
    Am J Gastroenterol. 2025 Nov 19. doi: 10.14309/ajg.0000000000003859.
    PubMed    
    Abstract available
    
    

75. ALGERA JP, Melchior C, Colomier E, Tornblom H, et al
    Hypersensitivity to the lactulose nutrient challenge test in irritable bowel syndrome - a non-invasive test of meal-related symptoms.
    Am J Gastroenterol. 2025 Nov 17. doi: 10.14309/ajg.0000000000003843.
    PubMed    
    Abstract available
    
    

76. 
    Summary for Patients: The Mediterranean Diet for Irritable Bowel Syndrome.
    Ann Intern Med. 2025 Oct 28. doi: 10.7326/ANNALS-25-01519.
    PubMed    
    
    
    

77. BAMIDELE JO, Brownlow GM, Flack RM, Buckle RL, et al
    The Mediterranean Diet for Irritable Bowel Syndrome : A Randomized Clinical Trial.
    Ann Intern Med. 2025 Oct 28. doi: 10.7326/ANNALS-25-01519.
    PubMed    
    Abstract available
    
    

78. CABAN M, Pikus E, Czarnecka-Chrebelska K, Oszajca K, et al
    Use of Sodium Butyrate and Its Microencapsulated Forms in Intestinal Diseases-Current Clinical Approach.
    Dig Dis Sci. 2025 Nov 14. doi: 10.1007/s10620-025-09536.
    PubMed    
    Abstract available
    
    

79. WEI Q, Rui M, Wang Y, Ng SC, et al
    Cost-effectiveness analysis of fecal microbiota transplantation for patients with irritable bowel syndrome.
    Digestion. 2025 Nov 11:1-21. doi: 10.1159/000549485.
    PubMed    
    Abstract available
    
    

80. OSGOOD PT, Perez M, Whitehead B, Fortunato JE, et al
    Dietary Therapy for Disorders of Gut-Brain Interaction.
    Gastroenterol Clin North Am. 2025;54:841-857.
    PubMed    
    Abstract available
    
    

81. BHARUCHA AE, Knowles CH, Malcolm A
    An Evidence-Based Practical Review on Common Benign Anorectal Disorders: Hemorrhoids, Anal Fissure, Dyssynergic Defecation, and Fecal Incontinence.
    Gastroenterology. 2025 Nov 14:S0016-5085(25)05798.
    PubMed    
    Abstract available
    
    

82. SHIHA MG, Manza F, Figueroa-Salcido OG, Ontiveros N, et al
    Global prevalence of self-reported non-coeliac gluten and wheat sensitivity: a systematic review and meta-analysis.
    Gut. 2025 Oct 28:gutjnl-2025-336304. doi: 10.1136/gutjnl-2025-336304.
    PubMed    
    Abstract available
    
    

83. ZHANG J, Chi J, Yao Y
    Comments on "Association Between Irritable Bowel Syndrome and Lower Urinary Tract Symptomatology: A Cross-Sectional Study in Mexican Population".
    J Clin Gastroenterol. 2025 Nov 14. doi: 10.1097/MCG.0000000000002283.
    PubMed    
    
    
    

84. YAO YH, Li SN, Yin Q, Liu L, et al
    Comment on "Associations of Long-Term Night Shift Work With Incident Irritable Bowel Syndrome: A Population-Based Cohort Study".
    J Gastroenterol Hepatol. 2025 Nov 3. doi: 10.1111/jgh.70140.
    PubMed    
    
    
    

85. BRENNER DM, Shin AS, Laitman AP, Deutsch JK, et al
    The Effectiveness of Plecanatide for Treating Constipation and Bloating in Patients Aged 18 to 40 Years With Irritable Bowel Syndrome: Utilization of a New Composite Trisymptom Endpoint.
    J Gastroenterol Hepatol. 2025 Nov 10. doi: 10.1111/jgh.70119.
    PubMed    
    Abstract available
    
    

86. GHOSHAL UC, Ramakrishna BS, Rathi PM, Shukla A, et al
    Probiotic Blend of Lactobacillus acidophilus LA-5 and Bifidobacterium animalis ssp. Lactis BB-12 in Non-constipated Irritable Bowel Syndrome: A Double-Blind Randomized Placebo-Controlled Trial.
    J Gastroenterol Hepatol. 2025 Nov 18. doi: 10.1111/jgh.70137.
    PubMed    
    Abstract available
    
    

87. WILD B, Stadnitski T, Benz-Sahnoun S, Guenther V, et al
    Pain patterns in patients with irritable bowel symptoms - A longitudinal observational time series approach.
    J Psychosom Res. 2025;200:112442.
    PubMed    
    Abstract available